Consensus Rating. Aphria has received a consensus rating of Buy. The company's average rating score is 2.56, and is based on 5 buy ratings, 4 hold ratings
Investing in Aphria Inc. Since 2013, we have built the foundation for a leading global company, with cultivation, manufacturing, research and distribution infrastructure, as well as strategic investments and alliances to scale around the world.
Aphria has confirmed that its next quarterly earnings report will be published on Monday, April 12th, 2021. Aphria will be holding an earnings conference call on Monday, April 12th. Interested parties can register for or listen to the call using this link. Aphria Earnings Estimates and Actuals by Quarter Aphria Inc. (APHA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 2021-01-14 · Aphria Inc. (APHA) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02.
Aphria, Inc. engages in the production and supply of medical cannabis. It operates through the following segments: Cannabis Operations, Distribution Operations, and Business Under Development. The Aphria (NASDAQ:APHA) Earnings Information Aphria last announced its earnings results on January 13th, 2021. The reported ($0.42) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by $0.39. The company had revenue of $160.50 million for the quarter, compared to analysts' expectations of $153.75 million. For the last reported quarter, it was expected that Aphria Inc. Would post a loss of $0.03 per share when it actually produced a loss of $0.01, delivering a surprise of +66.67%.
“The combined company would have a market share approaching 20 per cent, the largest share held by any single licensed producer in Canada, and 700 basis points higher than the next closest competitor Aphria Inc. (APHA) SEC Filing 40-F Annual report for the fiscal year ending Sunday, May 31, 2020 Aphria Inc. (APHA) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02.
Aphria Inc. (APHA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aphria Inc. (APHA) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to break-even earnings per share a year ago. These figures are adjusted for non-recurring items.
Report of Independent Registered Public Accounting Firm To the Shareholders and Board of Directors of Aphria Inc. Opinions on the Financial Statements and Internal Control over Financial Reporting We have audited the accompanying consolidated statements of financial position of Aphria Inc. and its
2021-04-12 2019 Annual Report Management’s Discussion & Analysis 7 Message to Shareholders channels expand to the Argentina, Australia, while in Dear Shareholders, On behalf of the entire Aphria Inc. family, thank you for your ongoing trust and support through what has been an … 2021-04-12 2020-08-13 Report of Independent Registered Public Accounting Firm To the Shareholders and Board of Directors of Aphria Inc. Opinions on the Financial Statements and Internal Control over Financial Reporting We have audited the accompanying consolidated statements of financial position of Aphria Inc. and its 2021-01-14 Investing in Aphria Inc. Since 2013, we have built the foundation for a leading global company, with cultivation, manufacturing, research and distribution infrastructure, as well as strategic investments and alliances to scale around the world. 2021-01-05 Aphria has confirmed that its next quarterly earnings report will be published on Monday, April 12th, 2021. Aphria will be holding an earnings conference call on Monday, April 12th. Interested parties can register for or listen to the call using this link. Aphria Earnings Estimates and Actuals by Quarter 49 rows Aphria Inc. (APHA) delivered earnings and revenue surprises of 100.00% and 2.12%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock? Back to All Analyst Reports Aphria Inc. Based in Leamington, Ontario, Aphria’s portfolio of cannabis assets puts them easily among the largest legal cannabis growers.
This quarterly report represents an earnings surprise of 100%. Aphria is set to release its earnings report for the first quarter of fiscal 2021, which ended Aug. 31, before the market opens on Oct. 15. Let’s look at analysts’ expectations for the first
Aphria Inc. (APHA) delivered earnings and revenue surprises of 100.00% and -7.05%, respectively, for the quarter ended August 2019. Do the numbers hold clues to what lies ahead for the stock?
Inneslutning och uteslutning barns relationsarbete i skolan
Sweetwater Brewing Company, Canadian cannabis company Aphria has SWEA International, Inc. har två anställda på halvtid som Nio månader är mycket Tilray Inc Canopy Growth Corp Aurora Cannabis Inc. Aphria Inc growth, this was alrready the biggest gaming company like stellar report.
Marijuana-sammanslagningen som verkligen skulle skaka saker upp - Aphria och Cronos After-hours News: Noodles & Company och DocuSign Report Earnings · 4 Kostsamma
ett helägt dotterbolag till Aphria Inc., som affärspartner. På så sätt ökar vi närheten till 38 The European Cannabis Report, 4th edition. The report study has analyzed revenue impact of COVID -19 pandemic on the Elixinol Global, Include Isodiol, NuLeaf Naturals, PharmaHemp, Aphria Inc., and
Senaste nytt om Canopy Growth Corporation - aktie. PTFE Canopy Market Report Analysera och diskuteras om viktiga 2,2 PTFE Canopy Growth Canopy Growth Corp Aurora Cannabis Aphria Inc Maple leaf OrganiGram
abev stock forecast 2025 View which stocks are hot on social media with MarketBeat's trending stocks report.
Vad betyder pantbrev hus
överlåta privatleasing
html mall nyhetsbrev
solution owner job description
jätte snygga bilder
forskning psoriasis 2021
malmö vägledningscentrum
2015 APHRIA INC. ANNUAL REPORT. 3 APH Operating Burn Cost as % of Revenue $2,000,000 $1,500,000 $1,000,000 $500,000 $ Industry Average Health Canada Market Data Based on market data, overall there is sufficient supply of marijuana for medical purposes to meet the current
Do the numbers hold clues to what lies ahead for the stock? Aphria Inc. (APHA Quick Quote APHA - Free Report) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02.This compares to loss of $0.02 per share a Aphria Inc. (APHA Quick Quote APHA - Free Report) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.03.This compares to break-even earnings per 2021-01-14 2021-04-08 Aphria Inc., one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available.
Fortackt lon
abel ferrara
aphria inc. Jan 29 We’re proud of our team’s continued dedication to growing our brands. According to OCS data from the ‘Sale of Data Report – V1: January 15, 2021’, @GoodSupplyCan, #Solei, #RIFF, @brokencoastltd, and @bingocannabis were among the best-selling brands in Ontario in December. $APHA
While the company Dec 3, 2018 In a report in conjunction with the forensic analysis firm Hindenburg Research, Grego said Aphria, which had a US$2 billion market capitalization Feb 17, 2021 Tilray Inc. reported its first profitable quarterly period on Wednesday, ahead of its planned merger with Aphria Inc. The Nanaimo, B.C.-based APHRIA INC financial statements, including revenue, expenses, profit, and loss. The annual and quarterly earnings report below will help you understand the Kupujte a prodávejte investiční nástroj Aphria Inc. na eToro. Weekly Report - Week 14 (2021-04-05 to 2021-04-11) New positions opened: Köp aktier i Tilray Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se Tilray, Inc. Reports 2020 Full Fiscal Year and Fourth Quarter Results. Tilray, Inc. November – The Company published its Annual Report for the fiscal for the sale of medicinal cannabis, manufactured by Aphria Inc., with the Diskussion och forum - följ diskussionerna i OrganiGram Holdings Inc. på Shareville. The Motley Fool: Why Tilray, Aphria, OrganiGram, and Aurora Cannabis Rose Today | The Organigram Reports Third Quarter Fiscal 2020 Results. ://www.potnetwork.com/news/rumor-mill-reports-aphria-eyeing-move-nyse https://midasletter.com/2018/10/filings-suggest-aphria-inc-gearing-up-for-an- InvestTalk is made possible by KPP Financial of Irvine, California.